(株)リボミックの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4591/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/02/19 | 日証協 | 623,100株 | +14.39% | 57,200株 | -49.82% | 481,278株 | +11.08% | 7,510株 | -88.75% |
2016/02/12 | 日証協 | 544,700株 | +6.03% | 114,000株 | +148.91% | 433,258株 | +4.29% | 66,734株 | +170.18% |
2016/02/05 | 日証協 | 513,700株 | +35.58% | 45,800株 | -62.02% | 415,434株 | +22.11% | 24,700株 | -3.59% |
2016/01/29 | 日証協 | 378,900株 | -13.37% | 120,600株 | +0.75% | 340,224株 | -8.08% | 25,620株 | -58.07% |
2016/01/22 | 日証協 | 437,400株 | +16.83% | 119,700株 | +42.67% | 370,114株 | +5.72% | 61,100株 | +48.99% |
2016/01/15 | 日証協 | 374,400株 | +22.75% | 83,900株 | +88.12% | 350,104株 | +17.89% | 41,010株 | -38.54% |
2016/01/08 | 日証協 | 305,000株 | +36.71% | 44,600株 | -33.33% | 296,984株 | +19.72% | 66,730株 | +1488.81% |
2015/12/30 | 日証協 | 223,100株 | -8.98% | 66,900株 | +651.69% | 248,074株 | -4.02% | 4,200株 | -37.31% |
2015/12/25 | 日証協 | 245,100株 | -7.89% | 8,900株 | -82.58% | 258,474株 | -14.59% | 6,700株 | -79.49% |
2015/12/18 | 日証協 | 266,100株 | +21.06% | 51,100株 | +78.67% | 302,644株 | +6.64% | 32,670株 | +20.36% |
2015/12/11 | 日証協 | 219,800株 | -8.19% | 28,600株 | +29.41% | 283,793株 | +0.97% | 27,144株 | +311.27% |
2015/12/04 | 日証協 | 239,400株 | -19.15% | 22,100株 | +67.42% | 281,068株 | -11.35% | 6,600株 | -23.26% |
2015/11/27 | 日証協 | 296,100株 | -2.57% | 13,200株 | -62.71% | 317,068株 | -1.86% | 8,600株 | +62.26% |
2015/11/20 | 日証協 | 303,900株 | +6.37% | 35,400株 | +331.71% | 323,068株 | +8.46% | 5,300株 | -29.33% |
2015/11/13 | 日証協 | 285,700株 | -5.11% | 8,200株 | -40.15% | 297,868株 | -7.31% | 7,500株 | -2.66% |
2015/11/06 | 日証協 | 301,100株 | +5.17% | 13,700株 | +67.07% | 321,368株 | +2.69% | 7,705株 | -34.15% |
2015/10/30 | 日証協 | 286,300株 | -9.23% | 8,200株 | -46.41% | 312,963株 | -2.34% | 11,700株 | -12.03% |
2015/10/23 | 日証協 | 315,400株 | -15.51% | 15,300株 | -57.73% | 320,463株 | -5.37% | 13,300株 | +19.82% |
2015/10/16 | 日証協 | 373,300株 | -6.06% | 36,200株 | -12.98% | 338,663株 | -5.89% | 11,100株 | +146.12% |
※株式分割は考慮していませんのでご注意ください。
Page Top